Dr. Hoadley’s research interests are focused on using genomics-based assays and analyses to understand tumor heterogeneity, determine tissue-specific effects of genomic alterations, and develop genomic predictors of response or resistance to therapy. Her graduate work on breast cancer and postgraduate work with the Cancer Genome Atlas (TCGA) developed her informatics skills to approach these research interests.
Katie received her BA in Chemistry and BS in Biology from West Virginia Wesleyan College in 2001 and her PhD in Genetics and Molecular Biology from UNC in 2006. Following a postdoctoral fellowship at Netherlands Cancer Institute, she returned to UNC for further postdoctoral work in the Lineberger Comprehensive Cancer Center and was subsequently appointed as a Research Associate. She was named to the fixed-term faculty in Genetics in 2013 and became an LCCC member in 2014, as part of the Cancer Genetics Program. Since 2017, she has served as Associate Director of Cancer Genomics for the High-Throughput Sequencing Facility. She has worked with the Cancer Genome Atlas (TCGA) program for the past twelve years, taking on increasing levels of responsibility, including the co-chair of the testicular germ cell tumor project (Cell Reports, 2018) and a Steering Committee member for our 33 tumor type Pan-cancer Atlas project (26 papers published in Cell family journals April 2018). Katie is a member of the Computational Medicine program at UNC and her future research will use the wealth of knowledge available from the vast amount of data already in the public domain to continue to genomically characterize human tumors with the goal of developing even more powerful predictors of prognosis and benefit of therapeutics.
The Department of Genetics is pleased to welcome Dr. Hoadley!
Katie is located in 5212 Marsico Hall and can be reached at 919-962-8416.